- /
- Supported exchanges
- / US
- / DRUG.NASDAQ
Bright Minds Biosciences Inc (DRUG NASDAQ) stock market data APIs
Bright Minds Biosciences Inc Financial Data Overview
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bright Minds Biosciences Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Bright Minds Biosciences Inc data using free add-ons & libraries
Get Bright Minds Biosciences Inc Fundamental Data
Bright Minds Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Bright Minds Biosciences Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -1.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bright Minds Biosciences Inc News
New
Bright Minds Biosciences And 2 More Canadian Biotech Stocks
Oil prices are climbing again as shipping attacks in the Gulf raise fresh worries about inflation and higher interest rates that can pressure many sectors. Canadian biotech stocks sit slightly off to ...
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
Bright Minds Biosciences NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company"), a clinical stage biotechnology compan...
Auxly Cannabis Group And 2 Other Canadian Biotech Stocks To Watch
Bond yields have surged to levels last seen before the global financial crisis, which makes future cash flows harder to value and puts every growth story under a harsher spotlight. That pressure has n...
FDA names acting heads of drug and vaccine units to permanent roles
[FDA Headquarters] The Trump administration on Tuesday appointed the acting heads of the FDA units overseeing drugs, vaccines, and tobacco to permanent positions weeks after nominating White House ad...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.